CNBC Merck to create separate cancer business to offset Keytruda patent loss
Merck said on Monday it will split its human-health business into two divisions, separating its cancer franchise from its non-oncology medicines.
Merck said on Monday it will split its human-health business into two divisions, separating its cancer franchise from its non-oncology medicines.